Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mekinist in Metastatic Uveal Melanoma
NCT01328106Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Nov 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of trametinib in Uveal melanoma (UM), melanoma, sponsored by GSK. Planned start Nov 2010; status: withdrawn.
02
Drugs
trametinib
03
Conditions
Uveal melanoma (UM)melanoma
Beyond the preview
Go deeper on NCT01328106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328106.